-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L5iUkvOry8Tw3162zs4QApCVJR7DJq/rpz+/hTLva2EhZcGjogklPD4ynCMz4vcW gFMkZOhgrj6EF+ZriHa24w== 0000950134-08-002545.txt : 20080214 0000950134-08-002545.hdr.sgml : 20080214 20080213214542 ACCESSION NUMBER: 0000950134-08-002545 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080214 DATE AS OF CHANGE: 20080213 GROUP MEMBERS: PROSPECT ASSOCIATES II LP GROUP MEMBERS: PROSPECT MANAGEMENT CO II LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HANSEN MEDICAL INC CENTRAL INDEX KEY: 0001276591 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-82535 FILM NUMBER: 08607750 BUSINESS ADDRESS: STREET 1: 380 NORTH BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650 404 5800 MAIL ADDRESS: STREET 1: 380 NORTH BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PROSPECT VENTURE PARTNERS II LP CENTRAL INDEX KEY: 0001135669 IRS NUMBER: 770565416 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 435 TASSO ST STREET 2: STE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 6503278800 MAIL ADDRESS: STREET 1: 435 TASSO STREET SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 SC 13G/A 1 f37830sc13gza.htm AMENDMENT TO SCHEDULE 13G sc13gza
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) and (d)
AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)
(Amendment No. 1)*
Hansen Medical, Inc.
 
(Name of Issuer)
Common Stock, par value $0.0001 per share
 
(Title of Class of Securities)
411307 10 1
 
(CUSIP Number)
December 31, 2007
 
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
      o Rule 13d-1(b)
 
      o Rule 13d-1(c)
 
      þ Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 

 

Table of Contents

                     
CUSIP NO.
  
411307 10 1  
 13 G Page  
2 
   of   
8 Pages 

 

           
1   NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Prospect Venture Partners II, L.P.
IRS No. 77-0565416
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a)   o
  (b)   þ (1)
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware, United States of America
       
  5   SOLE VOTING POWER
     
NUMBER OF   0 shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,387,529 shares of Common Stock (2)
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0 shares
       
WITH 8   SHARED DISPOSITIVE POWER
     
    1,387,529 shares of Common Stock (2)
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,387,529 shares of Common Stock (2)
     
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
   
  6.37% (3)
     
12   TYPE OF REPORTING PERSON*
   
  PN
(1) This Schedule 13G is filed by Prospect Venture Partners II, L.P., a Delaware limited partnership (“PVP II”), Prospect Associates II, L.P., a Delaware limited partnership (“PA II”), Prospect Management Co. II, L.L.C., a Delaware limited liability company (“PMC II,” together with PVP II and PA II, collectively, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2) Includes (i) 1,366,717 shares held by PVP II; and (ii) 20,812 shares held by PA II. PMC II serves as the general partner of PVP II and PA II, and owns no securities of the Issuer directly. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2007.
(3) This percentage is calculated based upon 21,773,726 shares of the Common Stock outstanding as of October 26, 2007 as reported on the Issuer’s 10-Q as filed with the Securities Exchange Commission on November 2, 2007.

Table of Contents

                     
CUSIP NO.
  
411307 10 1  
 13 G Page  
3 
   of   
8 Pages 

 

           
1   NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Prospect Associates II, L.P.
IRS No. 77-0584739
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a)   o
  (b)   þ (1)
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware, United States of America
       
  5   SOLE VOTING POWER
     
NUMBER OF   0 shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,387,529 shares of Common Stock (2)
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0 shares
       
WITH 8   SHARED DISPOSITIVE POWER
     
    1,387,529 shares of Common Stock (2)
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,387,529 shares of Common Stock (2)
     
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
   
  6.37% (3)
     
12   TYPE OF REPORTING PERSON*
   
  PN
(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2) Includes (i) 1,366,717 shares held by PVP II; and (ii) 20,812 shares held by PA II. PMC II serves as the general partner of PVP II and PA II, and owns no securities of the Issuer directly. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2007.
(3) This percentage is calculated based upon 21,773,726 shares of the Common Stock outstanding as of October 26, 2007 as reported on the Issuer’s 10-Q as filed with the Securities Exchange Commission on November 2, 2007.

Table of Contents

                     
CUSIP NO.
  
411307 10 1  
 13 G Page  
4 
   of   
8 Pages 

 

           
1   NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Prospect Management Co. II, L.L.C.
IRS No. 77-0565417
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a)   o
  (b)   þ (1)
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware, United States of America
       
  5   SOLE VOTING POWER
     
NUMBER OF   0 shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,387,529 shares of Common Stock (2)
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0 shares
       
WITH 8   SHARED DISPOSITIVE POWER
     
    1,387,529 shares of Common Stock (2)
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,387,529 shares of Common Stock (2)
     
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
   
  6.37% (3)
     
12   TYPE OF REPORTING PERSON*
   
  OO
(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2) Includes (i) 1,366,717 shares held by PVP II; and (ii) 20,812 shares held by PA II. PMC II serves as the general partner of PVP II and PA II, and owns no securities of the Issuer directly. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2007.
(3) This percentage is calculated based upon 21,773,726 shares of the Common Stock outstanding as of October 26, 2007 as reported on the Issuer’s 10-Q as filed with the Securities Exchange Commission on November 2, 2007.

TABLE OF CONTENTS

Item 1
Item 2
Item 3 Not applicable
Item 4 Ownership
Item 5 Ownership of Five Percent or Less of a Class
Item 6 Ownership of More Than Five Percent on Behalf of Another Person
Item 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company
Item 8 Identification and Classification of Members of the Group
Item 9 Notice of Dissolution of Group
Item 10 Certification
SIGNATURE

Table of Contents

Introductory Note: This Statement on Schedule 13G is filed on behalf of the Reporting Persons, in respect of shares of Common Stock, par value $0.0001 per share (“Common Stock”), of Hansen Medical, Inc. (the “Issuer”).
Item 1
(a)     Name of Issuer:         Hansen Medical, Inc.
(b)     Address of Issuer’s Principal Executive Offices:   380 North Bernardo Avenue
Mountain View, California 94043
Item 2
(a)   Name of Person(s) Filing:
Prospect Venture Partners II, L.P. (“PVP II”)
Prospect Associates II, L.P. (“PA II”)
Prospect Management Co. II, L.L.C. (“PMC II”)
(b)     Address of Principal Business Office:   c/o Prospect Venture Partners
435 Tasso Street, Suite 200
Palo Alto, California 94301
(c)    Citizenship:
                 
 
     Entities:   PVP II   -   Delaware, United States of America
 
      PA II   -   Delaware, United States of America
 
      PMC II   -   Delaware, United States of America
 
                
(d)       Title of Class of Securities:         Common Stock
(e)       CUSIP Number:         411307 10 1
Item 3   Not applicable.
Page 5 of 8 Pages

 

Table of Contents

Item 4   Ownership.
The following information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2007:
                                                         
            Sole   Shared   Sole   Shared        
    Shares Held   Voting   Voting   Dipositive   Dipositive   Beneficial   Percentage
Reporting Person   Directly   Power   Power   Power   Power   Ownership   of Class (2)
Prospect Venture Partners II, L.P.
     1,366,717       0       1,387,529       0       1,387,529       1,387,529       6.37 %
 
                                                        
Prospect Associates II, L.P.
     20,812       0       1,387,529       0       1,387,529       1,387,529       6.37 %
 
                                                        
Prospect Management Co. II, L.L.C. (1)
     0       0       1,387,529       0       1,387,529       1,387,529       6.37 %
 
                                                        
 
(1)   PMC II serves as the general partner of PVP II and PA II, and owns no securities of the Issuer directly. Schnell, Barkas, Tananbaum and Hirsch serve as Managing Directors of PMC II and share voting and dispositive power over the shares held by PVP II and PA II, but own no securities of the Issuer directly.
 
(2)   This percentage is calculated based upon 21,773,726 shares of the Common Stock outstanding as of October 26, 2007 as reported on the Issuer’s 10-Q as filed with the Securities Exchange Commission on November 2, 2007.
Item 5   Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof, the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following:      o
Item 6   Ownership of More Than Five Percent on Behalf of Another Person.
  Not applicable.
Item 7   Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.
  Not applicable.
Item 8   Identification and Classification of Members of the Group.
  Not applicable.
Item 9   Notice of Dissolution of Group.
  Not applicable.
Item 10   Certification.
  Not applicable.
Page 6 of 8 Pages

 

Table of Contents

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 13, 2008
     
PROSPECT VENTURE PARTNERS II, L.P.
    
 
    
By: Prospect Management Co. II, L.L.C.
    
Its: General Partner
    
 
    
/s/ Dave Markland
 
    
Dave Markland
    
Attorney-in-Fact
    
 
    
PROSPECT ASSOCIATES II, L.P.
    
 
    
By: Prospect Management Co. II, L.L.C.
    
Its: General Partner
    
 
    
/s/ Dave Markland
 
    
Dave Markland
    
Attorney-in-Fact
    
 
    
PROSPECT MANAGEMENT CO. II, L.L.C.
    
 
    
/s/ Dave Markland
 
    
Dave Markland
    
Attorney-in-Fact
    
 
    
 
    
Exhibit(s)
 
    
 
    
99.1 — Joint Filing Statement
 
    
Page 7 of 8 Pages

 

Table of Contents

Exhibit 99.1
AGREEMENT
     Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of the shares of Common Stock of Hansen Medical, Inc.
EXECUTED this 13th day of February, 2008.
PROSPECT VENTURE PARTNERS II, L.P.
     
By:
  Prospect Management Co. II, L.L.C.
Its:
  General Partner
     
/s/ Dave Markland
 
Dave Markland
   
Attorney-in-Fact
    
PROSPECT ASSOCIATES II, L.P.
     
By:
  Prospect Management Co. II, L.L.C.
Its:
  General Partner
     
/s/ Dave Markland
 
Dave Markland
   
Attorney-in-Fact
    
PROSPECT MANAGEMENT CO. II, L.L.C.
     
/s/ Dave Markland
 
    
Dave Markland
    
Attorney-in-Fact
    
 
    
Page 8 of 8 Pages

-----END PRIVACY-ENHANCED MESSAGE-----